Nuon Therapeutics Identifies Novel Use And Advances NU1618 Into Development For Chronic Hyperuricemia In Patients With …

Nuon Therapeutics Identifies Novel Use And Advances NU1618 Into Development For Chronic Hyperuricemia In Patients With …
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data [...]

NYU researchers identify novel therapy for rheumatoid arthritis

NYU researchers identify novel therapy for rheumatoid arthritis
By enhancing the activity of immune cells that protect against runaway inflammation, researchers at NYU Langone Medical Center may have found a novel therapy for rheumatoid arthritis and other autoimmune diseases.
Read more on News-Medical-Net

Novel antitoxin strategy developed using ‘tagged binding agents’

Novel antitoxin strategy developed using ‘tagged binding agents’
A study involving the world’s deadliest substance has yielded a new strategy to clear toxins from the body -which may lead to more efficient strategies against toxins that may be used in a bioterrorist event, as well as snake bites, scorpion stings, and even some important chronic diseases.
Read [...]